Nvidia Earnings Face Volatility After CEO Exit
Nvidia earnings face a risk after Jensen Huang's resignation as interim CEO Colette Kress will lead into the upcoming quarterly report, raising volatility.

KEY TAKEAWAYS
- Jensen Huang resigned and Colette Kress was named interim CEO.
- Fiscal Q3 2027 results are scheduled for Nov. 17 with a report around 4:20 p.m. ET.
- The leadership change may increase near-term volatility and prompt analyst reassessments.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
NVIDIA (NVDA) announced on November 12, 2026, that Jensen Huang resigned immediately as president, chief executive officer, and a board member. Chief Financial Officer Colette Kress will serve as interim CEO. This leadership change precedes Nvidia’s fiscal third-quarter 2027 results, scheduled for November 17, 2026, and may increase volatility.
Leadership Transition and Earnings Schedule
The company’s board appointed Harvey C. Jones as Nvidia’s first-ever chair and said it will conduct a search considering both internal and external candidates for a permanent CEO. Kress will retain her CFO responsibilities during the transition. In the November 12 press release, Kress said, "NVIDIA's strength has always come from its people."
The board announced Huang’s immediate resignation and Kress’s interim appointment. Fiscal third-quarter 2027 results are set for November 17, 2026, at approximately 4:20 p.m. Eastern Time, followed by an earnings call at 5 p.m. The release provided a reporting schedule but did not include quarterly revenue, gross margin, earnings per share, or forward guidance figures. Nvidia’s investor-relations SEC index lists a Form 8-K dated November 12, 2026, filing ID 19923299.
Recent Technology Announcements and Risk Disclosures
On November 16, 2026, Nvidia announced collaborations with IBM and the U.S. Department of Energy’s Fermi National Accelerator Laboratory on quantum-classical computing. The company also introduced the Vera CPU platform to accelerate scientific discovery and unveiled Nemotron for Science, designed to speed discoveries with agents.
These releases included standard risk disclosures covering third-party manufacturing, technological development and competition, product acceptance and performance, defects, demand changes, and changes in law or regulation.
Investors will receive the company’s fiscal third-quarter results and management commentary at the scheduled report and follow-up call. Those disclosures will provide official figures and any updated outlook that could influence near-term trading and analyst assessments.





